1. Home
  2. HIHO vs VRAX Comparison

HIHO vs VRAX Comparison

Compare HIHO & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Highway Holdings Limited

HIHO

Highway Holdings Limited

BUY

Current Price

$0.89

Market Cap

4.1M

Sector

Industrials

ML Signal

BUY

VRAX

Virax Biolabs Group Limited

N/A

Current Price

$2.85

Market Cap

2.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HIHO
VRAX
Founded
1990
2013
Country
Hong Kong
United Kingdom
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1M
2.1M
IPO Year
2002
2021

Fundamental Metrics

Financial Performance
Metric
HIHO
VRAX
Price
$0.89
$2.85
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.00
AVG Volume (30 Days)
34.3K
481.2K
Earning Date
03-02-2026
06-12-2026
Dividend Yield
14.99%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$217,274.83
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.60
$0.10
52 Week High
$2.21
$13.19

Technical Indicators

Market Signals
Indicator
HIHO
VRAX
Relative Strength Index (RSI) 45.27 50.34
Support Level $0.87 $2.55
Resistance Level $0.93 $3.10
Average True Range (ATR) 0.04 0.19
MACD -0.00 -0.02
Stochastic Oscillator 63.60 29.59

Price Performance

Historical Comparison
HIHO
VRAX

About HIHO Highway Holdings Limited

Highway Holdings Ltd is a holding company. Along with its subsidiaries, it operates as a fully integrated manufacturer of high-quality metal, plastic, electric and electronic components, subassemblies, and finished products for OEMs and contract manufacturers. The manufacturing services offered by the group include metal stamping, screen printing, plastic injection molding, pad printing, and electronic assembly of printed circuit boards. Its reportable business segments are metal stamping and mechanical OEM operations, which derive maximum revenue, and electric OEM operations. Geographically, the group generates maximum revenue from Europe, and the rest from North America, Hong Kong and China, and other Asian countries.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.

Share on Social Networks: